Detalles de la búsqueda
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38055253
2.
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol
; 185: 186-193, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447347
3.
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite.
Br J Clin Pharmacol
; 90(2): 568-581, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37872122
4.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol
; 170: 241-247, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736157
5.
A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States.
BMC Cancer
; 22(1): 502, 2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524219
6.
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer.
Future Oncol
; 18(21): 2667-2682, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611679
7.
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Gynecol Oncol
; 156(3): 523-529, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916979
8.
Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care Settings.
J Genet Couns
; 2018 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29770910
9.
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Lancet Oncol
; 18(3): 384-392, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28159465
10.
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Lancet Oncol
; 16(3): 301-11, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25638326
11.
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 139(3): 541-5, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26456812
12.
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.
Int J Gynecol Cancer
; 24(9): 1583-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25254563
13.
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
J Clin Oncol
; 41(13): 2436-2445, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36716407
14.
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancer.
Gynecol Oncol
; 127(3): 564-8, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22940492
15.
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics.
PLoS One
; 17(2): e0264637, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35213669
16.
A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone.
Appl Immunohistochem Mol Morphol
; 30(4): 237-245, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384873
17.
Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study.
Appl Immunohistochem Mol Morphol
; 30(1): 27-35, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34224438
18.
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.
Obstet Gynecol
; 133(2): 245-254, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633128
19.
Reply to Z.R. McCaw et al.
J Clin Oncol
; 41(29): 4705-4706, 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535884
20.
Regulated delivery of molecular cargo to invasive tumour-derived microvesicles.
Nat Commun
; 6: 6919, 2015 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25897521